Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

Bernardino, JI; Mocroft, A; Wallet, C; de Wit, S; Katlama, C; Reiss, P; Mallon, PW; ... NEAT001/ANRS143 Trial Study Group, ; + view all Bernardino, JI; Mocroft, A; Wallet, C; de Wit, S; Katlama, C; Reiss, P; Mallon, PW; Richert, L; Molina, J-M; Knobel, H; Morlat, P; Babiker, A; Pozniac, A; Raffi, F; Arribas, JR; NEAT001/ANRS143 Trial Study Group, ; - view fewer (2019) Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial. PLoS One , 14 (1) , Article e0209911. 10.1371/journal.pone.0209911 . Green open access

http://bit.ly/2trgo1J